These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32620445)
21. Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.). Singh A; Shaikh A; Singh R; Singh AK Diabetes Metab Syndr; 2020; 14(5):865. PubMed ID: 32562863 [No Abstract] [Full Text] [Related]
22. Editorial commentary: Hitting a moving target: The challenge of creating consensus treatment protocols for cardiovascular care during the coronavirus pandemic. Yang E; Marine JE Trends Cardiovasc Med; 2020 Aug; 30(6):326-327. PubMed ID: 32562772 [No Abstract] [Full Text] [Related]
23. Letter to the editor in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)". Kumar Singh A; Singh R Diabetes Metab Syndr; 2020; 14(5):937-938. PubMed ID: 32593934 [No Abstract] [Full Text] [Related]
24. The impacts of the novel SARS-CoV-2 outbreak on surgical oncology - A letter to the editor on "The socio-economic implications of the coronavirus and COVID-19 pandemic: A review". Shubber N; Sheppard J; Alradhawi M; Ali Y Int J Surg; 2020 Jul; 79():109-110. PubMed ID: 32439572 [No Abstract] [Full Text] [Related]
25. Reply to Chand et al. regarding letter to the Editor regarding the article: 'Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)'. Ghoshal S; Diabetes Metab Syndr; 2020; 14(5):1541. PubMed ID: 32947752 [No Abstract] [Full Text] [Related]
26. CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic. Linschoten M; Asselbergs FW Eur Heart J; 2020 May; 41(19):1795-1796. PubMed ID: 32267494 [No Abstract] [Full Text] [Related]
27. Letter to the Editor in response to the article: "Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis" (Ghoshal et al.). Chand R; Asmil SH; Chico M Diabetes Metab Syndr; 2020; 14(5):1305. PubMed ID: 32755826 [No Abstract] [Full Text] [Related]
28. Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the Gupta AK; Jneid H; Addison D; Ardehali H; Boehme AK; Borgaonkar S; Boulestreau R; Clerkin K; Delarche N; DeVon HA; Grumbach IM; Gutierrez J; Jones DA; Kapil V; Maniero C; Mentias A; Miller PS; Ng SM; Parekh JD; Sanchez RH; Sawicki KT; Te Riele ASJM; Remme CA; London B J Am Heart Assoc; 2020 Jun; 9(12):e017013. PubMed ID: 32347144 [TBL] [Abstract][Full Text] [Related]
29. How is the cardiovascular patient managed during Covid-19 pandemic? A report from the frontline. Cortese B Catheter Cardiovasc Interv; 2020 Nov; 96(5):E565. PubMed ID: 32433798 [No Abstract] [Full Text] [Related]
30. Letter to the Editor Regarding Nogueira et al "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal". Fernandes N Acta Med Port; 2020 Sep; 33(9):625. PubMed ID: 33160422 [No Abstract] [Full Text] [Related]
31. Susceptibility and prognosis of COVID-19 patients with cardiovascular disease. Wang BX Open Heart; 2020 Jun; 7(1):. PubMed ID: 32587104 [No Abstract] [Full Text] [Related]
32. Letter to editor in response to article "COVID-19: From bench to bedside" (Singh et al.). Singh H; Dhibar DP Diabetes Metab Syndr; 2020; 14(5):807. PubMed ID: 32535453 [No Abstract] [Full Text] [Related]
33. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic. Yeo TJ; Wang YL; Low TT Eur J Prev Cardiol; 2020 Jun; 27(9):903-905. PubMed ID: 32233671 [No Abstract] [Full Text] [Related]
35. Response to Almalki Almadi MA; Aljebreen AM; Azzam N; Batwa F Saudi J Gastroenterol; 2020; 26(5):285-286. PubMed ID: 32893842 [No Abstract] [Full Text] [Related]
36. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.). Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A Diabetes Metab Syndr; 2020; 14(5):1147-1148. PubMed ID: 32668400 [No Abstract] [Full Text] [Related]
38. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment. Chatterjee NA; Cheng RK Heart; 2020 Aug; 106(15):1119-1121. PubMed ID: 32451360 [No Abstract] [Full Text] [Related]
39. Letter in response to the article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.). Santacroce L Diabetes Metab Syndr; 2020; 14(5):927. PubMed ID: 32585601 [No Abstract] [Full Text] [Related]
40. Response to the letter of L. Santacroce regarding article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.). Jayawardena R; Sooriyaarachchi P; Chourdakis M; Jeewandara C; Ranasinghe P Diabetes Metab Syndr; 2020; 14(5):839. PubMed ID: 32540739 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]